Introduction. Uterine cervical cancer is the first cause of incidence and mortality in Colombian women. Nearly 10% of all the cases in the country are treated at the Instituto Nacional de Cancerología. Evaluation of the institutional success rates is suggested.Objective. Patient survival over a 5 year period was summarized for those admitted for treatment of cervical cancer at the Institute in the year 2000.Materials and methods. All patients with cervical cancer at the Institute in 2000 were included in the survival analysis. Frequencies, central tendencies and dispersion measures were used to describe categorical and numerical variables. Survival analysis was performed by using Kaplan Meier and the multivariate Cox regression model.Result...
Background: This report shows the effect of period of diagnosis and treatment in the breast cancer s...
Introduction. Despite the implementation of cytological screening since 1991, cervical cancer contin...
El cáncer de endometrio corresponde al 4.8% de las neoplasias ginecológicas en países desarrollados....
Introduction. Uterine cervical cancer is the first cause of incidence and mortality in Colombian wom...
Uterine cervical cancer is a leading cause of death from cancer in the female population worldwide. ...
OBJECTIVE: To assess overall survival of women with cervical cancer and describe prognostic factors ...
ResumenIntroducciónMundialmente, el cáncer cervicouterino es el cuarto tipo de cáncer más frecuente ...
Objetivo: describir las características sociodemográficas y de salud de las pacientes con cáncer inv...
Background: There is limited information on population-based cancer survival data in Latin America. ...
Objetivo: Estimar la probabilidad acumulada de sobrevida a cinco años, de una cohorte de pacientes d...
Introduction: Cervical cancer represents one of leading causes of death by cancer in the female popu...
OBJECTIVE: To assess overall survival of women with cervical cancer and describe prognostic factors ...
Introduction: Despite of having a program, for a long time, to the early detection of cervical ut...
OBJETIVO: Avaliar a sobrevida global de mulheres com câncer de colo uterino e identificar fatores pr...
70 PáginasRecurso ElectrónicoEl cáncer de cuello uterino es la patología neoplásica maligna de mayor...
Background: This report shows the effect of period of diagnosis and treatment in the breast cancer s...
Introduction. Despite the implementation of cytological screening since 1991, cervical cancer contin...
El cáncer de endometrio corresponde al 4.8% de las neoplasias ginecológicas en países desarrollados....
Introduction. Uterine cervical cancer is the first cause of incidence and mortality in Colombian wom...
Uterine cervical cancer is a leading cause of death from cancer in the female population worldwide. ...
OBJECTIVE: To assess overall survival of women with cervical cancer and describe prognostic factors ...
ResumenIntroducciónMundialmente, el cáncer cervicouterino es el cuarto tipo de cáncer más frecuente ...
Objetivo: describir las características sociodemográficas y de salud de las pacientes con cáncer inv...
Background: There is limited information on population-based cancer survival data in Latin America. ...
Objetivo: Estimar la probabilidad acumulada de sobrevida a cinco años, de una cohorte de pacientes d...
Introduction: Cervical cancer represents one of leading causes of death by cancer in the female popu...
OBJECTIVE: To assess overall survival of women with cervical cancer and describe prognostic factors ...
Introduction: Despite of having a program, for a long time, to the early detection of cervical ut...
OBJETIVO: Avaliar a sobrevida global de mulheres com câncer de colo uterino e identificar fatores pr...
70 PáginasRecurso ElectrónicoEl cáncer de cuello uterino es la patología neoplásica maligna de mayor...
Background: This report shows the effect of period of diagnosis and treatment in the breast cancer s...
Introduction. Despite the implementation of cytological screening since 1991, cervical cancer contin...
El cáncer de endometrio corresponde al 4.8% de las neoplasias ginecológicas en países desarrollados....